Who Joined Us in 2025?
Here's a small sample of the attendees from the Medical Affairs Community:
Senior Vice President, Head of Medical Affairs , BMS
Chief Compliance Officer, Kura Oncology
Vice President, Head of Global Scientific Communications, GSK
Executive Director, Worldwide Medical Oncology, Medical Communications, BMS
Vice President, Head of Patient & Scientific Engagement, Bayer
National Director, Field Medical – Transplant, Veloxis Pharmaceuticals
Global Head, Medical Affairs Excellence, Boehringer Ingelheim
Executive Director, Publications, Mirum Pharmaceuticals
Vice President and Head of US Medical Affairs, Genmab
Director, Medical Communications, Exact Sciences
Head of Field Medical, Adaptimmune
Senior Director, Head of US Field Medical Affairs, Genmab
Senior Vice President, US Medical Affairs, GSK
Vice President, Global Medical Affairs, Head of Medical Excellence in Oncology, AstraZeneca
Senior Director, Health Economics & Outcomes Research (HEOR), Alkermes, Inc.
Senior Director, Global Medical Unit Head – Rare Growth & Launch Products Global Medical Affairs, Takeda
Senior Vice President Medical Affairs, CSL Behring
Vice President, Head of Global Medical Affairs, Rocket Pharmaceuticals
Global Lead, Oncology Field Medical Excellence, Pfizer
Head, Medical Insights and Analytics-Medical Affairs Oncology, Regeneron Pharmaceuticals
Vice President, Global Medical Affairs, Hematology, Johnson & Johnson
Franchise Head, US Medical Affairs, GI Cancers, AtraZeneca
Director of Learning & Development, Medical Affairs, Acadia Pharmaceutical
Senior Director, HEOR, Medical Affairs, Acadia Pharmaceuticals
Director, Medical Affairs Digital Excellence, Astellas
Senior Vice President and Specialty Business Unit Head, GSK
Patient Engagement & Professional Relations, Genmab
Vice President, Medical Affairs, Azurity Pharmaceuticals
Patient Engagement R&D Lead, Bayer
Vice President, Head of Medical Channel Excellence, Pfizer
Senior Director, Medical Analytics & Intelligence, Global Medical Affairs Oncology, Daiichi Sankyo, Inc
Vice President, Customer Engagement RLT Oncology Platform, Novartis
Director, Internal Medicine Migraine Field Medical, Pfizer
Vice President US Medical Affairs, BioNTech
Head, Global Innovation Capability Enablement Omnichannel Strategy Operations (OSO), Astellas
Vice President, US Medical Affairs , Apellis Pharmaceuticals
Regional Director, Medical Affairs , Vertex Pharmaceuticals
Senior Director, Channel Integration and Innovation Lead, Global Scientific Communications , GSK
Regional Medical Director, Amicus Therapeutics
Director, Medical Omnichannel and Content Strategy, AstraZeneca
Sr. Medical Science Liaison, Azurity Pharmaceuticals Inc.
Sr. Medical Affairs Manager, Azurity Pharmaceuticals Inc.
Sr Director, Medical Affairs, Gilead Sciences
Senior Manager Clinical Regulatory Affairs, Knight Therapeutics
Global Director, Omnichannel Medical, Merck & Co., Inc.
Senior Director, U.S. FMA Planning & Operations, Otsuka
Director, North America Medical Affairs, Regeneron Pharmaceuticals
Sr. Medical Science Liaison, Veloxis Pharmaceuticals
2025 Featured Medical Affairs Sessions:
2025 Featured Medical Affairs Speakers:
%20Photo%20(1)-transformed.jpg)
Key Topics in the Medical Affairs Community:
Evolve Medical Affairs Leadership to Navigate a Changing Healthcare Landscape
Develop an Integrated Omnichannel Strategy to Enhance HCP Engagement
Leverage MSL Insights to Drive Clinical and Commercial Strategy Alignment
Maximize Stakeholder Engagement by Balancing Digital and Face-to-Face Interactions
Harness AI and Data to Optimize Medical Affairs Decision-Making and Strategy
Utilize Digital Tools to Strengthen MSL Field Engagement and Knowledge Sharing
Your pass unlocks every community—Marketing, PR, Medical Affairs & Commercialization.
You Can’t Get This Level of Access Anywhere Else.
Connect with 2,200+ top-tier life science executives across medical, marketing, communications, and commercial roles – 72% Director level or above.
As an exhibitor or partner of Fierce Pharma Week, you will have unrivaled access to a powerful audience looking to learn, buy new products, and connect with businesses like yours.
Attendees utilize the conference to help drive commercial value and go-to-market strategies. From marketing and sales, medical affairs and scientific communications, new product planning and commercial development, and PR and communications, we’ve got the right buyers for you.
Let's work together!
Find out why Fierce Pharma Week is the ultimate networking opportunity to reach key decision makers across every corner of the biopharma ecosystem.